Intraperitoneal therapy for stage III ovarian cancer: A therapy whose time has come!

被引:45
作者
Alberts, DS [1 ]
Markman, M
Armstrong, D
Rothenberg, ML
Muggia, F
Howell, SB
机构
[1] Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA
[2] Cleveland Clin Fdn, Cleveland, OH USA
[3] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] NYU Med Ctr, New York, NY 10016 USA
[6] Univ Calif San Diego, La Jolla, CA 92093 USA
关键词
D O I
10.1200/JCO.2002.20.19.3944
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3944 / 3946
页数:3
相关论文
共 8 条
  • [1] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
    Alberts, DS
    Liu, PY
    Hannigan, EV
    OToole, R
    Williams, SD
    Young, JA
    Franklin, EW
    ClarkePearson, DL
    Malviya, VK
    DuBeshter, B
    Adelson, MD
    Hoskins, WJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) : 1950 - 1955
  • [2] Armstrong DK, 2002, P AN M AM SOC CLIN, V21, p201a
  • [3] Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
    Markman, M
    Bundy, BN
    Alberts, DS
    Fowler, JM
    Clark-Pearson, DL
    Carson, LF
    Wadler, S
    Sickel, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1001 - 1007
  • [4] Intraperitoneal therapy for ovarian cancer: A sacrifice bunt
    McGuire, WP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 921 - 923
  • [5] Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    McGuire, WP
    Hoskins, WJ
    Brady, MF
    Kucera, PR
    Partridge, EE
    Look, KY
    ClarkePearson, DL
    Davidson, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (01) : 1 - 6
  • [6] OZOLS F, 1999, P AM SOC CLIN ONCOL, V18, pA356
  • [7] ROSE PG, 2002, P AN M AM SOC CLIN, V21, pA201
  • [8] ROTHENBERG ML, 2002, P AM SOC CLIN ONCOL, V21, pA203